Cefaclor and Chronic thyroiditis - a phase IV clinical study of FDA data

Summary:

Chronic thyroiditis is reported as a side effect among people who take Cefaclor (cefaclor), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Keppra, and have Malignant melanoma.

The phase IV clinical study analyzes which people have Chronic thyroiditis when taking Cefaclor. It is created by eHealthMe based on reports of 2,472 people who have side effects when taking Cefaclor from the FDA, and is updated regularly.

What is Cefaclor?

Cefaclor has active ingredients of cefaclor. eHealthMe is studying from 2,512 Cefaclor users. Check the latest studies of Cefaclor.

What is Chronic thyroiditis?

Chronic thyroiditis (long lasting inflammation of thyroid gland) is found to be associated with 457 drugs and 1,084 conditions by eHealthMe. Check the latest studies of Chronic thyroiditis.

On Jul, 08, 2026

2,472 people reported to have side effects when taking Cefaclor.
Among them, 12 people (0.49%) have Chronic thyroiditis.

Could Cefaclor cause Chronic thyroiditis?

Among these 12 people:

How long have people been on Cefaclor when they have Chronic thyroiditis? *

What is the gender of people who have Chronic thyroiditis when taking Cefaclor? *

female: 50 %
male: 50 %

What is the age of people who have Chronic thyroiditis when taking Cefaclor? *

What are other drugs people take besides Cefaclor? *

What are other side effects people have besides Chronic thyroiditis? *

Autoimmune Hepatitis: 6 people, 50.00%
Malignant Neoplasm Progression (cancer tumour came back): 6 people, 50.00%
Cholecystitis (infection of gallbladder): 6 people, 50.00%
Linear Iga Disease (a rare, idiopathic or drug-induced autoimmune blistering disease of skin): 5 people, 41.67%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 4 people, 33.33%
Circulatory Collapse: 4 people, 33.33%
Haemolytic Anaemia (anaemia due to haemolysis): 4 people, 33.33%
Thrombocytosis: 4 people, 33.33%
Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 8.33%
Drug Resistance (reduction in effectiveness of a drug): 1 person, 8.33%

What are the existing conditions these people have? *

Malignant Melanoma (skin cancer rises from melancytes): 6 people, 50.00%
Metastases To Central Nervous System (cancer spreads to central nervous system): 5 people, 41.67%
Facial Paralysis (loss of function of face muscle): 5 people, 41.67%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 5 people, 41.67%
Sinusitis (inflammation of sinus): 1 person, 8.33%
Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cefaclor and have Chronic thyroiditis?

- Check whether Chronic thyroiditis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefaclor:

Cefaclor (2,512 reports)

Browse all side effects of Cefaclor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chronic thyroiditis:

Chronic thyroiditis (457 drugs)

Browse all the conditions that are associated with Chronic thyroiditis:

Chronic thyroiditis (1,084 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefaclor (the active ingredients of Cefaclor) and Cefaclor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.